+33 (0)6 47 17 67 07 contact@nexialist.fr
  • 
  •  Contact
  • Français
  • English
Nexialist - votre partenaire pour la conformité des dispositifs médicaux
  • The company
    • Discover Nexialist
    • Our team of experts
    • Recruitment area
  • Your needs
  • Our solutions
    • AQUILA – NEW
    • Phaos
    • PYXIS
    • nex’inform
    • Our solutions
  • News & Uptades
    • MDCG
    • Artificial Intelligence
    • Clinical evaluation
    • Corporate
    • Digital health
    • Electrical devices
    • Innovation
    • PMS / PMCF
    • Process / Production
    • Quality
    • Regulation
    • Risk management
    • Software
    • Technical documentation
    • Unique Device Identification System (UDI System)
    • GLOSSARY
Select Page

MDCG 2020-10/1 Rev. 1 : Safety reporting in clinical investigations of medical devices under the Regulation (EU) 2017/745 – May 2020

24 Nov 2020 | MDCG

Theme Clinical investigation Target audience Sponsors (Manufacturer, Legal Representative or Contact Person) Products concerned Investigational MD Regulatory references MDR (EU) 2017/745 Article 80(2)   This document defines the modalities for reporting Serious...

MDCG 2020-9 : Regulatory requirements for ventilators and related accessories – April 2020

24 Nov 2020 | MDCG

Theme Ventilators – Covid-19 Target Audience Manufacturers, Notified Bodies Product concerned MD : Ventilators and their accessories Regulatory reference MDR (EU) 2017/745 Article 59   MDD 93/42/EEC Article 11(13) Documents mentioned EN ISO/IEC 80601-2-12:2011 +...

MDCG 2020-8 : Post-market clinical follow-up (PMCF) Evaluation Report Template. A guide for manufacturers and notified bodies – April 2020

24 Nov 2020 | MDCG

Theme Post-market Clinical Follow-up Target audience Manufacturers, Notified bodies Products concerned MD (including Legacy Devices)* Regulatory references MDR (EU) 2017/745 Article 61 Annex XIV – Part B     EN – This guide provides a detailed evaluation...

MDCG 2020-7 : Post-market clinical follow-up (PMCF) Plan Template. A guide for manufacturers and notified bodies – April 2020

24 Nov 2020 | MDCG

Theme Post-Market Clinical Follow-up Target audience Manufacturers, Notified bodies Product concerned MD (including Legacy Devices)* Regulatory references MDR (EU) 2017/745 Article 61 Annex XIV – Part B     EN – This guide provides a detailed template...

MDCG 2020-6 : Regulation (EU) 2017/745: Clinical evidence needed for medical devices previously CE marked under Directives 93/42/EEC or 90/385/EEC – April 2020

24 Nov 2020 | MDCG

Theme Clinical Evaluation – clinical evidence Target audience Manufacturer, Notified bodies Product concerned MD CE-marked  under Directives Regulatory reference MDR (EU) 2017/745 Article 61 Annex XIV – Part A Documents mentioned MEDDEV 2.7/1  rev. 4 (2016) : Clinical...
« Older Entries
Next Entries »

Search in the Website

All the topics

  • Clinical evaluation
  • Corporate
  • Digital health
  • Electrical devices
  • Innovation
  • MDCG
  • PMS / PMCF
  • Process / Production
  • Quality
  • Regulation
  • Risk management
  • Unique Device Identification System (UDI System)

#Tags

Animal origin Biocompatibility Borderline Classification Clinical trials Datas Homologation Labeling Matières premières Medical devices Mise sur le marché Placing on the market Qualification Retraitement Sterilization Usability

Archives

Contact us

Le Forum Bat B
515 Avenue de La Tramontane
13600 La Ciotat
FRANCE

+33 (0)4 42 01 60 29
Write us

Nexialist

Nexialist : Intelligence règlementaire et conformité des produits de santé

About us

Nexialist works with companies in the medical device sector, including in vitro diagnostic and advanced therapy devices. We provide assistance with any compliance, quality, and regulatory-related challenges as well as product development and commercialisation strategy.

Legal informations

  • Privacy policy
  • Legal notice
  • Sitemap

Nexialist’s universe

  • NEXIALIST
  • NEXINFORM

Follow us on…

© NEXIALIST - Réalisation : Nathalie Brunelli, Mirobolus 2019